Want to see OTRKQ full AI Analyst Report?
Top Page
Ontrak
(OTC:OTRKQ)
Select Model
Select Model
Rating:38Underperform
Price Target:
$0.00
▼(-100.00% Downside)
Action:Reiterated
Date:10/23/25
Ontrak’s extremely low score is driven by critical financial distress—including deeply negative margins, persistent cash burn, escalating leverage, and a fundamental lack of earnings power—alongside a prolonged technical downtrend and no valuation or income support. There are no material technical or valuation positives to offset these risks; bankruptcy risk is high without a radical operational turnaround.
Positive Factors
Strategic Partnerships
Strategic partnerships with health insurers expand Ontrak's market reach and service offerings, potentially driving long-term revenue growth and enhancing competitive positioning in the healthcare technology sector.
Negative Factors
Declining Revenue
Declining revenue indicates potential market challenges and operational inefficiencies, which could hinder growth and profitability if not addressed through strategic adjustments.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Partnerships
Strategic partnerships with health insurers expand Ontrak's market reach and service offerings, potentially driving long-term revenue growth and enhancing competitive positioning in the healthcare technology sector.
Read all positive factors
Ontrak (OTRKQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$708.00
Dividend YieldN/A
Average Volume (3M)94.04K
Price to Earnings (P/E)―
Beta (1Y)-109.24
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees104
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,084,537
10 Day Avg. Volume63,585
30 Day Avg. Volume94,037
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.84
Price to Sales (P/S)0.77
P/FCF Ratio-0.61
Enterprise Value/Market Cap0.02
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Ontrak Business Overview & Revenue Model
Company Description
Ontrak, Inc. is a virtualized healthcare company that leverages artificial intelligence and telehealth to deliver services, including in-person components, to health plans and other third-party payors across the United States. Its sophisticated, t...
How the Company Makes Money
Ontrak generates revenue primarily through contracts with health plans and employers, where it provides its behavioral health intervention programs. The company's revenue model is based on a fee-for-service structure, often incorporating performan...
Ontrak Financial Statement Overview
Summary
Income Statement
19
Very Negative
Balance Sheet
23
Negative
Cash Flow
14
Very Negative
| Breakdown | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.85M | 12.74M | 14.51M | 84.13M | 82.84M |
| Gross Profit | 6.82M | 8.80M | 7.05M | 52.92M | 39.23M |
| EBITDA | -22.59M | -14.42M | -42.38M | -24.65M | -14.21M |
| Net Income | -25.49M | -27.92M | -51.57M | -37.14M | -22.71M |
Balance Sheet | |||||
| Total Assets | 21.07M | 19.85M | 25.76M | 93.68M | 144.70M |
| Cash, Cash Equivalents and Short-Term Investments | 5.71M | 9.70M | 5.03M | 58.82M | 86.91M |
| Total Debt | 8.50M | 1.69M | 11.26M | 37.45M | 48.73M |
| Total Liabilities | 11.21M | 5.58M | 20.08M | 48.13M | 83.95M |
| Stockholders Equity | 9.87M | 14.27M | 5.68M | 45.55M | 60.75M |
Cash Flow | |||||
| Free Cash Flow | -13.61M | -15.78M | -25.12M | -30.64M | -8.04M |
| Operating Cash Flow | -13.44M | -15.50M | -23.97M | -26.16M | -6.28M |
| Investing Cash Flow | -177.00K | -285.00K | -1.16M | -4.48M | -4.64M |
| Financing Cash Flow | 9.62M | 15.77M | -31.11M | -6.63M | 100.11M |
Ontrak Risk Analysis
Ontrak disclosed 61 risk factors in its most recent earnings report. Ontrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ontrak Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $7.37B | 65.54 | 30.25% | ― | 49.76% | ― | |
73 Outperform | $1.32B | 316.64 | 1.84% | ― | 47.63% | ― | |
64 Neutral | $12.27B | 40.48 | 15.23% | ― | 19.91% | 350.11% | |
52 Neutral | $1.11B | -6.15 | -13.08% | ― | -2.08% | 16.88% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $469.20M | -0.93 | -99.16% | ― | -4.50% | -184.71% | |
38 Underperform | $708.00 | ― | -211.17% | ― | ― | ― |
* Healthcare Sector Average
OTRKQ
Ontrak
0.06
0.02
50.00%
EVH
Evolent Health
4.17
-4.85
-53.77%
TDOC
Teladoc
6.09
-1.59
-20.70%
BTSG
BrightSpring Health Services, Inc.
57.88
31.43
118.83%
HNGE
Hinge Health, Inc. Class A
88.26
30.63
53.15%
OMDA
Omada Health, Inc.
21.50
-0.46
-2.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.